Visual Outcome After Vitrectomy With Subretinal tPA Injection

N/ACompletedNCT05196139

Universitaire Ziekenhuizen KU Leuven96 enrolled

Overview

evaluate the safety of Eva surgical system

The purpose of this retrospective study is to evaluate the safety and clinical results using this surgical technique when performed using the EVA surgical system and associated instrumentation and disposable surgical equipment

Study Type

OBSERVATIONAL

Enrollment

Conditions

Age-Related Macular Degeneration

Interventions

retrospective studyOTHER

vitrectomy performed in case of submacular bleeding

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients with VTX subretinal tPA ( + phaco) * patients with submacular bleeding Exclusion Criteria: * none

Locations (1)

UZ Leuven

Leuven, Belgium

Outcomes

Primary Outcomes

pre-operative best corrected visual acuity

• The pre-operative BCVA will be taken from the visit when the indication for the surgery was set

Time frame: pre surgery

Surgical adverse events

Surgical adverse events or issues that were recorded in the surgical report

Time frame: postoperative visit on day 1

post-operative best corrected visual acuity

The post-operative BCVA will be taken from the latest visit after the surgical procedure

Time frame: 6 weeks after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.